2020-2029 Report on Global Biologics and Biosimilars Market by Player, Region, Type, Application and Sales Channel
- Report Code : MAR2061660
- Published On: Oct, 2020
- Category : Healthcare & Pharma
- Pages : 117
-
The global Biologics and Biosimilars market was valued at $XX million in 2019, and Research analysts predict the global market size will reach $XX million by the end of 2029, growing at a CAGR of XX% between 2020 and 2029.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 210 countries and territories around the world and 2 international conveyances. The global impacts of COVID-19 are already starting to be felt, and will significantly affect this industry in 2020.
This report analyses the impact of COVID-19 on this industry. COVID-19 can affect the global market in 3 ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on enterprises and financial markets.
This report provides detailed historical analysis of global market for Biologics and Biosimilars from 2014-2019, and provides extensive market forecasts from 2020-2029 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the Biologics and Biosimilars market.
Leading players of Biologics and Biosimilars including:
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck
3sbio
Changchun High Tech
CP Guojian
Biotech
Gelgen
Innovent
Dong Bao
Ganlee
Market split by Type, can be divided into:
Monoclonal Antibodies
Interferon
Erythropoietin
Insulin
Vaccines
Other
Market split by Application, can be divided into:
Tumor
Diabetes
Cardiovascular
Hemophilia
Other
Market split by Sales Channel, can be divided into:
Direct Channel
Distribution Channel
Market segment by Region/Country including:
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia and Spain etc.)
Asia-Pacific (China, Japan, Korea, India, Australia and Southeast Asia etc.)
South America (Brazil, Argentina and Colombia etc.)
Middle East & Africa (South Africa, UAE and Saudi Arabia etc.)
If you have any special requirements, please let us know and we can provide you the customized report as you want.
-
With tables and figures helping analyze worldwide Report on Global Biologics and Biosimilars Market by market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.
Chapter 1 Biologics and Biosimilars Market Overview1.1 Biologics and Biosimilars Definition
1.2 Global Biologics and Biosimilars Market Size Status and Outlook (2014-2029)
1.3 Global Biologics and Biosimilars Market Size Comparison by Region (2014-2029)
1.4 Global Biologics and Biosimilars Market Size Comparison by Type (2014-2029)
1.5 Global Biologics and Biosimilars Market Size Comparison by Application (2014-2029)
1.6 Global Biologics and Biosimilars Market Size Comparison by Sales Channel (2014-2029)
1.7 Biologics and Biosimilars Market Dynamics (COVID-19 Impacts)
1.7.1 Market Drivers/Opportunities
1.7.2 Market Challenges/Risks
1.7.3 Market News (Mergers/Acquisitions/Expansion)
1.7.4 COVID-19 Impacts on Current Market
1.7.5 Post-Strategies of COVID-19 Outbreak
Chapter 2 Biologics and Biosimilars Market Segment Analysis by Player2.1 Global Biologics and Biosimilars Sales and Market Share by Player (2017-2019)
2.2 Global Biologics and Biosimilars Revenue and Market Share by Player (2017-2019)
2.3 Global Biologics and Biosimilars Average Price by Player (2017-2019)
2.4 Players Competition Situation & Trends
2.5 Conclusion of Segment by Player
Chapter 3 Biologics and Biosimilars Market Segment Analysis by Type3.1 Global Biologics and Biosimilars Market by Type
3.1.1 Monoclonal Antibodies
3.1.2 Interferon
3.1.3 Erythropoietin
3.1.4 Insulin
3.1.5 Vaccines3.2 Global Biologics and Biosimilars Sales and Market Share by Type (2014-2019)
3.3 Global Biologics and Biosimilars Revenue and Market Share by Type (2014-2019)
3.4 Global Biologics and Biosimilars Average Price by Type (2014-2019)
3.5 Leading Players of Biologics and Biosimilars by Type in 2019
3.6 Conclusion of Segment by Type
Chapter 4 Biologics and Biosimilars Market Segment Analysis by Application4.1 Global Biologics and Biosimilars Market by Application
4.1.1 Tumor
4.1.2 Diabetes
4.1.3 Cardiovascular
4.1.4 Hemophilia
4.1.5 Other4.2 Global Biologics and Biosimilars Sales and Market Share by Application (2014-2019)
4.3 Leading Consumers of Biologics and Biosimilars by Application in 2019
4.4 Conclusion of Segment by Application
Chapter 5 Biologics and Biosimilars Market Segment Analysis by Sales Channel5.1 Global Biologics and Biosimilars Market by Sales Channel
5.1.1 Direct Channel
5.1.2 Distribution Channel5.2 Global Biologics and Biosimilars Sales and Market Share by Sales Channel (2014-2019)
5.3 Leading Distributors/Dealers of Biologics and Biosimilars by Sales Channel in 2019
5.4 Conclusion of Segment by Sales Channel
Chapter 6 Biologics and Biosimilars Market Segment Analysis by Region6.1 Global Biologics and Biosimilars Market Size and CAGR by Region (2014-2029)
6.2 Global Biologics and Biosimilars Sales and Market Share by Region (2014-2019)
6.3 Global Biologics and Biosimilars Revenue and Market Share by Region (2014-2019)
6.4 North America
6.4.1 North America Market by Country
6.4.2 North America Biologics and Biosimilars Market Share by Type
6.4.3 North America Biologics and Biosimilars Market Share by Application
6.4.4 United States
6.4.5 Canada
6.4.6 Mexico6.5 Europe
6.5.1 Europe Market by Country
6.5.2 Europe Biologics and Biosimilars Market Share by Type
6.5.3 Europe Biologics and Biosimilars Market Share by Application
6.5.4 Germany
6.5.5 UK
6.5.6 France
6.5.7 Italy
6.5.8 Russia
6.5.9 Spain6.6 Asia-Pacific
6.6.1 Asia-Pacific Market by Country
6.6.2 Asia-Pacific Biologics and Biosimilars Market Share by Type
6.6.3 Asia-Pacific Biologics and Biosimilars Market Share by Application
6.6.4 China
6.6.5 Japan
6.6.6 Korea
6.6.7 India
6.6.8 Southeast Asia
6.6.9 Australia
6.7 South America
6.7.1 South America Market by Country
6.7.2 South America Biologics and Biosimilars Market Share by Type
6.7.3 South America Biologics and Biosimilars Market Share by Application
6.7.4 Brazil
6.7.5 Argentina
6.7.6 Colombia
6.8 Middle East & Africa
6.8.1 Middle East & Africa Market by Country
6.8.2 Middle East & Africa Biologics and Biosimilars Market Share by Type
6.8.3 Middle East & Africa Biologics and Biosimilars Market Share by Application
6.8.4 UAE
6.8.5 Saudi Arabia
6.8.6 South Africa
6.9 Conclusion of Segment by Region
Chapter 7 Profile of Leading Biologics and Biosimilars Players7.1 Roche
7.1.1 Company Snapshot
7.1.2 Product/Service Offered
7.1.3 Business Performance (Sales, Price, Revenue, Gross Margin and Market Share)
7.1.4 COVID-19 Impact on Roche7.2 Amgen
7.3 AbbVie
7.4 Sanofi-Aventis
7.5 Johnson & Johnson
7.6 Pfizer
7.7 Novo Nordisk
7.8 Eli Lilly
7.9 Novartis7.10 Merck
7.11 3sbio
7.12 Changchun High Tech
7.13 CP Guojian
7.14 Biotech
7.15 Gelgen
7.16 Innovent
7.17 Dong Bao
7.18 Ganlee
Chapter 8 Upstream and Downstream Analysis of Biologics and Biosimilars8.1 Industrial Chain of Biologics and Biosimilars
8.2 Upstream of Biologics and Biosimilars
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.2.4 Manufacturing Cost Structure
8.2.5 Manufacturing Process8.3 Downstream of Biologics and Biosimilars
8.3.1 Leading Distributors/Dealers of Biologics and Biosimilars
8.3.2 Leading Consumers of Biologics and Biosimilars
Chapter 9 Development Trend of Biologics and Biosimilars (2020-2029)9.1 Global Biologics and Biosimilars Market Size (Sales and Revenue) Forecast (2020-2029)
9.2 Global Biologics and Biosimilars Market Size and CAGR Forecast by Region (2020-2029)
9.3 Global Biologics and Biosimilars Market Size and CAGR Forecast by Type (2020-2029)
9.4 Global Biologics and Biosimilars Market Size and CAGR Forecast by Application (2020-2029)
9.5 Global Biologics and Biosimilars Market Size and CAGR Forecast by Sales Channel (2020-2029)
Chapter 10 Appendix10.1 Research Methodology
10.2 Data Sources
10.3 Disclaimer
10.4 Analysts Certification
-
The Report on Global Biologics and Biosimilars Market by Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.
Report Objectives / Segmentation Covered :
By Companies / players:
By Regions:
By Type:
By Application:
Frequently asked questions(FAQ's):
MI used a variety of industry standards such as NAICS, ICB, TRIC, and others to identify functional players in the industry, which they then shortlist and validate in an iterative process to finalize the most relevant players.
According to the report, the Report on Global Biologics and Biosimilars Market by Industry will grow to USD XXX Million by 2029, with a YY% CAGR.
A handful of disruptive trends, nevertheless, will have a contradictory and significant impact on the development of the Report on Global Biologics and Biosimilars Market by Market as well as its distribution among its players
This latest research publication on the Report on Global Biologics and Biosimilars Market by Market is an in-depth market tracker that provides a comprehensive assessment of the challenges that manufacturers face in achieving new growth cycles in the current scenario.
